blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1859049

EP1859049 - MARKERS FOR MELANOMA [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.12.2010
Database last updated on 13.09.2024
Most recent event   Tooltip10.12.2010Application deemed to be withdrawnpublished on 12.01.2011  [2011/02]
Applicant(s)For all designated states
UNIVERSITY COLLEGE DUBLIN
Belfield
Dublin 4 / IE
[2007/48]
Inventor(s)01 / GALLAGHER, William, Conway Institute
University Colege Dublin
Dublin 4 / IE
 [2007/48]
Representative(s)Spencer, Matthew Peter, et al
Boult Wade Tennant
Verulam Gardens
70 Gray's Inn Road
London WC1X 8BT / GB
[N/P]
Former [2007/48]Spencer, Matthew Peter, et al
Boult Wade Tennant Verulam Gardens 70 Gray's Inn Road
London WC1X 8BT / GB
Application number, filing date06709980.402.03.2006
[2007/48]
WO2006GB00756
Priority number, dateGB2005000430202.03.2005         Original published format: GB 0504302
[2007/48]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006092610
Date:08.09.2006
Language:EN
[2006/36]
Type: A2 Application without search report 
No.:EP1859049
Date:28.11.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 08.09.2006 takes the place of the publication of the European patent application.
[2007/48]
Search report(s)International search report - published on:EP07.12.2006
ClassificationIPC:C12Q1/68
[2007/48]
CPC:
C12Q1/6886 (EP); C12Q2600/112 (EP); C12Q2600/136 (EP);
C12Q2600/154 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/48]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:MELANOMMARKER[2007/48]
English:MARKERS FOR MELANOMA[2007/48]
French:MARQUEURS DE MÉLANOME[2007/48]
Entry into regional phase18.09.2007National basic fee paid 
18.09.2007Designation fee(s) paid 
18.09.2007Examination fee paid 
Examination procedure18.09.2007Examination requested  [2007/48]
30.01.2008Despatch of a communication from the examining division (Time limit: M06)
01.07.2008Reply to a communication from the examining division
21.11.2008Despatch of a communication from the examining division (Time limit: M06)
01.06.2009Reply to a communication from the examining division
06.05.2010Despatch of a communication from the examining division (Time limit: M02)
16.07.2010Application deemed to be withdrawn, date of legal effect  [2011/02]
24.08.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2011/02]
Fees paidRenewal fee
25.03.2008Renewal fee patent year 03
31.03.2009Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.03.201005   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO2004031410  (ONCOTHERAPY SCIENCE, INC; JAPAN AS REPRESENTED BY THE PRESIDENT OF THE) [X] 21-23 * claim 22 *;
 [X]WO2005005601  (THE REGENTS OF THE UNIVERSITY OF MICHIGAN; CLARKE, MICHAEL, F; LIU, RU) [X] 21-23 * This document discloses microarrays having TSPY1, MTA2, and CYBA . *;
 [A]WO0141815  (WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH; MASSACHUSETTS INSTITUTE O) [A] 1-30 * the whole document *
 [DX]  - SERRANO ALFONSO ET AL, "Expression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-Aza-2'-deoxycytidine treatment", INTERNATIONAL JOURNAL OF CANCER, NEW YORK, NY, US, (20011015), vol. 94, no. 2, ISSN 0020-7136, pages 243 - 251, XP002348088 [DX] 17-20 * the whole document *

DOI:   http://dx.doi.org/10.1002/ijc.1452
 [DX]  - VAN DER VELDEN PIETER A ET AL, "Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development.", INTERNATIONAL JOURNAL OF CANCER, (20030910), vol. 106, no. 4, ISSN 0020-7136, pages 472 - 479, XP002389348 [DX] 17-20 * the whole document *

DOI:   http://dx.doi.org/10.1002/ijc.11262
 [X]  - JANSSEN B L M ET AL, "TRANSCRIPTION OF THE MAGE-1 GENE AND THE METHYLATION STATUS OF ITS ETS BINDING PROMOTER ELEMENTS: A QUANTITATIVE ANALYSIS IN MELANOMA CELL LINES USING A REAL-TIME POLYMERASE CHAIN REACTION TECHNIQUE", MELANOMA RESEARCH, (1999), vol. 9, no. 3, pages 213 - 222, XP009029709 [X] 17-20 * the whole document *
 [X]  - APARICIO A ET AL, "Phase I trial of continuous infusion 5-aza-2'-deoxycytidine.", CANCER CHEMOTHERAPY AND PHARMACOLOGY, (200303), vol. 51, no. 3, ISSN 0344-5704, pages 231 - 239, XP002389349 [X] 17-20 * the whole document *
 [DX]  - WANG ENA ET AL, "Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness", CANCER RESEARCH, (20020701), vol. 62, no. 13, ISSN 0008-5472, pages 3581 - 3586, XP002389350 [DX] 21-23 * the whole document *

DOI:   http://dx.doi.org/10.1007/0-306-47822-6_1
 [A]  - BERGER AARON J ET AL, "Automated quantitative analysis of HDM2 expression in malignant melanoma shows association with early-stage disease and improved outcome", CANCER RESEARCH, (20041201), vol. 64, no. 23, ISSN 0008-5472, pages 8767 - 8772, XP002389352 [A] 1-30 * the whole document *

DOI:   http://dx.doi.org/10.1158/0008-5472.CAN-04-1384
 [DA]  - BITTNER M ET AL, "MOLECULAR CLASSIFICATION OF CUTANEOUS MALIGNANT MELANOMA BY GENE EXPRESSION PROFILING", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, (20000803), vol. 406, no. 6795, ISSN 0028-0836, pages 536 - 540, XP000990000 [DA] 1-30 * the whole document *

DOI:   http://dx.doi.org/10.1038/35020115
 [DA]  - CLARK E A ET AL, "Genomic analysis of metastasis reveals an essential role for RhoC", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, (20000803), vol. 406, no. 6795, ISSN 0028-0836, pages 532 - 535, XP002333028 [DA] 1-30 * the whole document *

DOI:   http://dx.doi.org/10.1038/35020106
Examination   - DASARI ET AL, "DNA METHYLATION REGULATES THE EXPRESSION OF Y CHROMOSOME SPECIFIC GENES IN PROSTATE CANCER", JOURNAL OF UROLOGY, BALTIMORE, MD, US, (20020101), vol. 167, no. 1, pages 335 - 338, XP005543608

DOI:   http://dx.doi.org/10.1016/S0022-5347(05)65464-X
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.